Zeng Z - Search Results

1

DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Du S, Chen G, Yuan B, Hu Y, Yang P, Chen Y, Zhao Q, Zhou J, Fan J, Zeng Z. Du S, et al. Among authors: zeng z. Cell Mol Immunol. 2021 Jul;18(7):1718-1728. doi: 10.1038/s41423-020-0395-x. Epub 2020 Mar 19. Cell Mol Immunol. 2021. PMID: 32203191 Free PMC article.

2

Phase I clinical trial of oral furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study.

Zeng ZC, Tang ZY, Wu ZQ, Ma ZC, Fan J, Qin LX, Zhou J, Wang JH, Wang BL, Zhong CS. Zeng ZC, et al. Am J Clin Oncol. 2000 Oct;23(5):449-54. doi: 10.1097/00000421-200010000-00004. Am J Clin Oncol. 2000. PMID: 11039502 Clinical Trial.

3

Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.

Zeng ZC, Tang ZY, Yang BH, Liu KD, Wu ZQ, Fan J, Qin LX, Sun HC, Zhou J, Jiang GL. Zeng ZC, et al. Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1657-68. doi: 10.1007/s00259-002-0996-x. Epub 2002 Oct 3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12458401

4

Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial.

Zeng ZC, Tang ZY, Yang BH, Fan J, Qin LX, Jiang GL, Zhou J, Sun HC, Cheng JM, Wang JH. Zeng ZC, et al. Hepatogastroenterology. 2004 Jan-Feb;51(55):201-7. Hepatogastroenterology. 2004. PMID: 15011864 Clinical Trial.

5

A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Yu Y, Wang JH, Guo W. Zeng ZC, et al. Cancer J. 2004 Sep-Oct;10(5):307-16. doi: 10.1097/00130404-200409000-00008. Cancer J. 2004. PMID: 15530260

6

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.

Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ. Zeng ZC, et al. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):432-43. doi: 10.1016/j.ijrobp.2004.05.025. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667964

7

Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Zhang JY, Yu Y, Cheng JM, Wang XL, Guo W. Zeng ZC, et al. Jpn J Clin Oncol. 2005 Feb;35(2):61-7. doi: 10.1093/jjco/hyi020. Jpn J Clin Oncol. 2005. PMID: 15709088

8

Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.

Zeng ZC, Tang ZY, Fan J, Qin LX, Ye SL, Zhou J, Sun HC, Wang BL, Wang JH. Zeng ZC, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1067-76. doi: 10.1016/j.ijrobp.2005.03.058. Int J Radiat Oncol Biol Phys. 2005. PMID: 15913915

9

Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS. Zeng ZC, et al. Cancer J. 2006 Mar-Apr;12(2):113-22. Cancer J. 2006. PMID: 16630402

10

Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.

Zeng ZC, Fan J, Tang ZY, Zhou J, Wang JH, Wang BL, Guo W. Zeng ZC, et al. Cancer Sci. 2008 Dec;99(12):2510-7. doi: 10.1111/j.1349-7006.2008.00981.x. Epub 2008 Nov 17. Cancer Sci. 2008. PMID: 19032365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,958 results

Search Page

Filters